Personality disorders improve in patients treated for major depression

Acta Psychiatrica Scandinavica

Volumn 122, Issue 3, 2010, Pages 219-225

  Mulder, R T ^a   Joyce, P R ^a   Frampton, C M A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

depression; personality disorders; treatment response

Indexed keywords

FLUOXETINE; NORTRIPTYLINE;

ADULT; ANTISOCIAL BEHAVIOR; ARTICLE; ATYPICAL DEPRESSION; BIPOLAR II DISORDER; BORDERLINE STATE; COMPULSIVE PERSONALITY DISORDER; CONVALESCENCE; FEMALE; HISTRIONIC PERSONALITY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MELANCHOLIA; NARCISSISM; OUTCOME ASSESSMENT; OUTPATIENT; PARANOID PERSONALITY DISORDER; PERSONALITY DISORDER; PRIORITY JOURNAL; SCHIZOIDISM; SCHIZOTYPAL PERSONALITY DISORDER; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; NORTRIPTYLINE; PERSONALITY ASSESSMENT; PERSONALITY DISORDERS;

EID: 77954975584     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01502.x     Document Type: Article

References (28)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders DSM-III, 3rd edn.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders DSM-IV, 4th edn.
3. Cohen P, Crawford TN, Johnson JG, Kasen S. The children in the community study of developmental course of personality disorder. J Pers Disord 2005 19 : 466 486.
4. Skodol AE, Gunderson JG, Shea MT et al. The Collaborative Longitudinal Personality Disorders Study (CLPS): overview and implications. J Pers Disord 2005 19 : 487 504.
5. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow-up. J Pers Disord 2005 19 : 505 523.
6. Grilo CM, McGlashan TH, Quinlan DM, Walker ML, Greenfeld D, Edell WS. Frequency of personality disorders in two age cohorts of psychiatric inpatients. Am J Psychiatry 1998 155 : 140 142.
7. Zanarini MC, Frankenburg FR, Hennen J, Silk KR. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry 2003 160 : 274 283.
8. Mulder RT. Depression and personality disorder. Curr Psychiatry Rep 2004 6 : 51 57.
9. Joyce PR, Mulder RT, Luty SE et al. Patterns and predictors of response, remission and recovery in major depression treated with fluoxetine or nortriptyline. Aust NZ J Psychiatry 2002 36 : 384 391.
10. Mulder RT, Joyce PR, Luty SE. The relationship of personality disorders to treatment outcome in depressed outpatients. J Clin Psychiatry 2003 64 : 259 264.
11. Spitzer R, Williams JB, Gibbon M. Structured Clinical Interview for DSM-III-R: Personality disorders (SCID-II, 3/1/87).
12. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979 134 : 382 389.
13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960 23 : 56 62.
14. Derogatis L, Lipman R, Covi L. SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychopharmacol Bull 1973 9 : 13 28.
15. Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 1976 33 : 1111 1115.
16. Mulder RT, Joyce PR, Frampton CMA, Luty SE, Sullivan PF. Six months of treatment for depression: outcome and predictors of the course of illness. Am J Psychiatry 2006 163 : 95 100.
17. Mulder RT, Frampton CMA, Luty SE, Joyce PR. Eighteen months of drug treatment for depression: predicting relapse and recovery. J Affect Disord 2008 141 : 263 270.
18. Fava M, Farabaugh AH, Sickinger AH et al. Personality disorders and depression. Psychol Med 2002 32 : 1049 1057.
19. Ferro T, Klein DN, Schwartz JE, Kasch KL, Leader JB. 30-month stability of personality disorder diagnoses in depressed outpatients. Am J Psychiatry 1998 155 : 653 659.
20. Johnson JG, Williams JB, Goetz RR, Rabkin JG, Lipsitz JD, Remien RH. Stability and change in personality disorder symptomatology: findings from a longitudinal study of HIV+ and HIV- men. J Abnorm Psychol 1997 106 : 154 158.
21. Mattanah JJ, Becker DF, Levy KN, Edell WS, McGlashan TH. Diagnostic stability in adolescents followed up 2 years after hospitalization. Am J Psychiatry 1995 152 : 889 894.
22. Loranger A, Lenzenweger M, Gartner A et al. Trait-state artifacts and the diagnosis of personality disorders. Arch Gen Psychiatry 1991 48 : 720 728.
23. Zimmerman M. Diagnosing personality disorders. A review of issues and research methods. Arch Gen Psychiatry 1994 51 : 225 245.
24. Mulder RT, Joyce PR. Relationship of temperament and behaviour measures to the prolactin response to fenfluramine in depressed men. Psychiatry Res 2002 109 : 221 228.
25. Farabaugh A, Mischoulon D, Yeung A et al. Predictors of stable personality disorder diagnoses in outpatients with remitted depression. J Nerv Ment Dis 2002 190 : 248 256.
26. Mulder RT. Personality pathology and treatment outcome in major depression: a review. Am J Psychiatry 2002 159 : 359 371.
27. Markovitz PJ, Calabrese JR, Schulz SC, Meltzer HY. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991 148 : 1064 1067.
28. Kapfhammer HP, Hippius H. Special feature: pharmacotherapy in personality disorders. J Pers Disord 1998 12 : 277 288.